Skip to Content

Join the 'Zolpidem' group to help and get support from people like you.

Zolpidem News

FDA Puts Tough Warning Label on Ambien, Lunesta, Other Sleep Aids

TUESDAY, April 30, 2019 – Many Americans use prescription sleep meds such as Ambien, Lunesta and Sonata to get good shut-eye. But the U.S. Food and Drug Administration on Tuesday slapped a tough new...

FDA Requires Stronger Warnings About Rare But Serious Incidents Related to Certain Prescription Insomnia Medicines

April 30, 2019 – The U.S. Food and Drug Administration today announced the agency is requiring a new boxed warning – the agency’s most prominent warning – on certain prescription insomnia drugs to be...

Sleeping Pills May Be Poor Choice for Dementia Patients

WEDNESDAY, July 25, 2018 – Giving dementia patients sleeping pills might raise their risk of broken bones, a new study suggests. Researchers compared data from nearly 3,000 dementia patients who...

Managing Anxiety

THURSDAY, Nov. 2, 2017 – A little bit of stress can motivate you, but too much might cause an anxiety disorder that can prevent you from living your life to the fullest. If you feel anxious on a...

Could You Be Overdoing It With Sleeping Pills?

WEDNESDAY, Oct. 4, 2017 – More Americans are having trouble getting a good night's sleep, a national health survey found. And the number of people who use prescription sleeping pills in the quest...

1 in 3 Seniors Take Sleep Aids

WEDNESDAY, Sept. 27, 2017 – One-third of older Americans take something to help them sleep, but most don't discuss their sleep problems with a doctor, a new survey finds. "Although sleep problems...

FDA Medwatch Alert: Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Including Ambien, Ambien CR, Edluar, and Zolpimist  [UPDATE 05/14/2013] Today, the U.S. Food and Drug Administration (FDA) is notifying the public that FDA has approved label changes specifying new ...

FDA Medwatch Alert: Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Including Ambien, Ambien CR, Edluar, and Zolpimist    [Posted 01/10/2013] ISSUE: FDA is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that ...

FDA Approves Intermezzo for Middle-of-the-Night Waking Followed by Difficulty Returning to Sleep

November 23, 2011 – The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night...

Ask a Question

Further Information

Related Condition Support Groups

Insomnia

Related Drug Support Groups

Ambien

Zolpidem Patient Information at Drugs.com